{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:09:26Z","timestamp":1792634966747,"version":"4.5.0"},"reference-count":41,"publisher":"American Society for Clinical Investigation","issue":"1","license":[{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008276","name":"College of Medicine, University of Florida","doi-asserted-by":"crossref","award":["HD052682"],"award-info":[{"award-number":["HD052682"]}],"id":[{"id":"10.13039\/100008276","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,2]]},"DOI":"10.1172\/jci173510","type":"journal-article","created":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T12:00:54Z","timestamp":1700568054000},"source":"Crossref","is-referenced-by-count":155,"title":["Thrombotic microangiopathy following systemic AAV administration is dependent on anti-capsid antibodies"],"prefix":"10.1172","volume":"134","author":[{"given":"Stephanie M.","family":"Salabarria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Corti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6289-4711","authenticated-orcid":false,"given":"Kirsten E.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6032-482X","authenticated-orcid":false,"given":"Megan B.","family":"Wichman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Berthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Precilla","family":"D\u2019Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3931-1207","authenticated-orcid":false,"given":"Cynthia J.","family":"Tifft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland W.","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa E.","family":"Elder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence R.","family":"Shoemaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Leon-Astudillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Tavakkoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Kirn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7302-1756","authenticated-orcid":false,"given":"Barry J.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","published-online":{"date-parts":[[2024,1,2]]},"reference":[{"key":"B1","unstructured":"Sherafat R. Toxicity risks of adeno-associated virus (AAV) vectors for gene therapy (GT). Paper presented at: FDA Cellular, Tissue, and Gene Therapies Advisory Committee (CTGTAC) Meeting #70; September 2\u20133, 2021; Virtual. https:\/\/www.fda.gov\/media\/151969\/download Accessed November 1, 2023"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.12.007"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1706198"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0012-9"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1172\/JCI36891"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00341"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2019.103997"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2022.07.018"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00670"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.01.001"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01990-07"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1172\/JCI143780"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1172\/JCI37607"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2019.107453"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/v11020102"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00079"},{"key":"B17"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.675897"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-01-306647"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032713-120154"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.9.4580-4590.2002"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2021.022"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00082-09"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-02024-8"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30508"},{"key":"B26","unstructured":"Solid Biosciences. Solid Biosciences Provides SGT-001 Program Update. https:\/\/www.solidbio.com\/about\/media\/press-releases\/solid-biosciences-provides-sgt-001-program-update Updated November 12, 2019. Accessed November 1, 2023"},{"key":"B27","unstructured":"Pfizer. Pfizer\u2019s New Phase 1b Results of Gene Therapy in Ambulatory Boys with Duchenne Muscular Dystrophy (dmd) Support Advancement into Pivotal Phase 3. https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/pfizers-new-phase-1b-results-gene-therapy-ambulatory-boys Updated May 15, 2020. Accessed November 2, 2023"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2020.11.054"},{"key":"B29","unstructured":"Rocket Pharmaceuticals. Rocket Pharmaceuticals Announces Positive Gene Expression, Clinical BiomarkerPreliminary Functional Data from Phase 1 Trial of RP-A501 for the Treatment of Danon Disease. https:\/\/ir.rocketpharma.com\/news-releases\/news-release-details\/rocket-pharmaceuticals-announces-positive-gene-expression Updated December 8, 2020. Accessed November 1, 2023"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021006419"},{"key":"B31","unstructured":"George JN, Nester CM. Diagnostic approach to suspected TTP, HUS, or other thrombotic microangiopathy (TMA). https:\/\/www.uptodate.com\/contents\/diagnostic-approach-to-suspected-ttp-hus-or-other-thrombotic-microangiopathy-tma Updated July 11, 2023. Accessed November 1, 2023"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3233\/JND-200593"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-021-01107-6"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.4155\/bio-2022-0081"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1055\/a-1538-4936"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2022.11.007"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.13733"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-57893-z"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3301611"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2023.01.010"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2021.01.016"}],"container-title":["Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jci.org\/articles\/view\/173510\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T14:01:14Z","timestamp":1704117674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jci.org\/articles\/view\/173510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,2]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1,2]]},"published-print":{"date-parts":[[2024,1,2]]}},"alternative-id":["10.1172\/JCI173510"],"URL":"https:\/\/doi.org\/10.1172\/jci173510","relation":{},"ISSN":["1558-8238"],"issn-type":[{"value":"1558-8238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,2]]},"article-number":"e173510"}}